Key PointsQuantedge Capital added 212,600 shares of 10x Genomics in the first quarter; the estimated transaction value was $4.25 million based on quarterly average pricing.The quarter-end value of the position increased by $5.52 million, reflecting both the share addition and stock price appreciation.This change represents a 2.32% shift in the fund’s 13F reportable assets under management.After the trade, Quantedge holds 416,553 shares valued at…